CJC + Ipamorelin Blend

This research peptide blend combines CJC-1295 (No DAC), a growth hormone–releasing hormone (GHRH) analog, with Ipamorelin, a selective ghrelin receptor agonist. In laboratory settings, the combination has been studied for its dual interaction with GHRH and ghrelin pathways, with investigations focusing on receptor binding, signaling, and the modulation of hormone dynamics. Research Characteristics: Combination of a GHRH analog and a ghrelin receptor agonist Studied for dual-pathway interactions influencing growth hormone signaling Examined in controlled research models for receptor activity and endocrine regulation